These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 23985983

  • 1. Relevance of nasal potential difference in diagnosis of cystic fibrosis among children.
    Valiulis A, Skurvydienė I, Misevičienė V, Kasnauskienė J, Vaidelienė L, Utkus A.
    Medicina (Kaunas); 2013; 49(4):185-90. PubMed ID: 23985983
    [Abstract] [Full Text] [Related]

  • 2. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
    Sermet-Gaudelus I, Girodon E, Sands D, Stremmler N, Vavrova V, Deneuville E, Reix P, Bui S, Huet F, Lebourgeois M, Munck A, Iron A, Skalicka V, Bienvenu T, Roussel D, Lenoir G, Bellon G, Sarles J, Macek M, Roussey M, Fajac I, Edelman A.
    Am J Respir Crit Care Med; 2010 Oct 01; 182(7):929-36. PubMed ID: 20538955
    [Abstract] [Full Text] [Related]

  • 3. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I, Girodon E, Roussel D, Deneuville E, Bui S, Huet F, Guillot M, Aboutaam R, Renouil M, Munck A, des Georges M, Iron A, Thauvin-Robinet C, Fajac I, Lenoir G, Roussey M, Edelman A.
    Thorax; 2010 Jun 01; 65(6):539-44. PubMed ID: 20522854
    [Abstract] [Full Text] [Related]

  • 4. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A.
    BMC Pediatr; 2006 Oct 03; 6():25. PubMed ID: 17018149
    [Abstract] [Full Text] [Related]

  • 5. Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.
    Bagheri-Hanson A, Nedwed S, Rueckes-Nilges C, Naehrlich L.
    BMC Pulm Med; 2014 Oct 04; 14():156. PubMed ID: 25280757
    [Abstract] [Full Text] [Related]

  • 6. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?
    Ooi CY, Dupuis A, Ellis L, Jarvi K, Martin S, Ray PN, Steele L, Kortan P, Gonska T, Dorfman R, Solomon M, Zielenski J, Corey M, Tullis E, Durie P.
    Thorax; 2014 Mar 04; 69(3):254-60. PubMed ID: 24149827
    [Abstract] [Full Text] [Related]

  • 7. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
    Ooi CY, Dupuis A, Gonska T, Ellis L, Ni A, Jarvi K, Martin S, Ray P, Steele L, Kortan P, Dorfman R, Solomon M, Zielenski J, Corey M, Tullis E, Durie P.
    Ann Am Thorac Soc; 2014 May 04; 11(4):562-70. PubMed ID: 24697796
    [Abstract] [Full Text] [Related]

  • 8. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test.
    Delmarco A, Pradal U, Cabrini G, Bonizzato A, Mastella G.
    Eur Respir J; 1997 May 04; 10(5):1145-9. PubMed ID: 9163660
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
    Hubert D, Fajac I, Bienvenu T, Desmazes-Dufeu N, Ellaffi M, Dall'ava-Santucci J, Dusser D.
    J Cyst Fibros; 2004 Mar 04; 3(1):15-22. PubMed ID: 15463882
    [Abstract] [Full Text] [Related]

  • 10. Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test.
    Minso R, Schulz A, Dopfer C, Alfeis N, Barneveld AV, Makartian-Gyulumyan L, Hansen G, Junge S, Müller C, Ringshausen FCC, Sauer-Heilborn A, Stanke F, Stolpe C, Tamm S, Welte T, Dittrich AM, Tümmler B.
    BMJ Open Respir Res; 2020 Oct 04; 7(1):. PubMed ID: 33020115
    [Abstract] [Full Text] [Related]

  • 11. Reproducibility of nasal potential difference measurements in cystic fibrosis.
    Yaakov Y, Kerem E, Yahav Y, Rivlin J, Blau H, Bentur L, Aviram M, Picard E, Bdolah-Abram T, Wilschanski M.
    Chest; 2007 Oct 04; 132(4):1219-26. PubMed ID: 17890478
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Nasal Potential Difference and Intestinal Current Measurements as Surrogate Markers for CFTR Function.
    Wilschanski M, Yaakov Y, Omari I, Zaman M, Martin CR, Cohen-Cymberknoh M, Shoseyov D, Kerem E, Dasilva D, Sheth S, Uluer A, OʼSullivan BP, Freedman S.
    J Pediatr Gastroenterol Nutr; 2016 Nov 04; 63(5):e92-e97. PubMed ID: 27496797
    [Abstract] [Full Text] [Related]

  • 13. Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism.
    Aalbers BL, Yaakov Y, Derichs N, Simmonds NJ, De Wachter E, Melotti P, De Boeck K, Leal T, Tümmler B, Wilschanski M, Bronsveld I.
    J Cyst Fibros; 2020 Jul 04; 19(4):627-631. PubMed ID: 31331863
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C, Wilschanski M, Skalická V, Lebecque P, Southern KW, Sermet I, Munck A, Derichs N, Middleton PG, Hjelte L, Padoan R, Vasar M, De Boeck K.
    Thorax; 2009 Aug 04; 64(8):683-91. PubMed ID: 19318346
    [Abstract] [Full Text] [Related]

  • 15. The diagnosis of cystic fibrosis.
    De Boeck K, Vermeulen F, Dupont L.
    Presse Med; 2017 Jun 04; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
    [Abstract] [Full Text] [Related]

  • 16. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.
    Derichs N, Sanz J, Von Kanel T, Stolpe C, Zapf A, Tümmler B, Gallati S, Ballmann M.
    Thorax; 2010 Jul 04; 65(7):594-9. PubMed ID: 20627915
    [Abstract] [Full Text] [Related]

  • 17. [Correlation of results of immunocytochemical, electrophysiologic, and molecular studies in patients with cystic fibrosis].
    Glazkov PB, Ivashchenko TE, Mitkina EN, Gembitskaia TE, Orlov AV, Chermenskii AG, Baranov VS.
    Genetika; 2000 Sep 04; 36(9):1274-8. PubMed ID: 11042815
    [Abstract] [Full Text] [Related]

  • 18. Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.
    Tridello G, Menin L, Pintani E, Bergamini G, Assael BM, Melotti P.
    J Cyst Fibros; 2016 Sep 04; 15(5):579-82. PubMed ID: 27423539
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.
    Gonska T, Keenan K, Au J, Dupuis A, Chilvers MA, Burgess C, Bjornson C, Fairservice L, Brusky J, Kherani T, Jober A, Kosteniuk L, Price A, Itterman J, Morgan L, Mateos-Corral D, Hughes D, Donnelly C, Smith MJ, Iqbal S, Arpin J, Reisman J, Hammel J, van Wylick R, Derynck M, Henderson N, Solomon M, Ratjen F.
    Pediatrics; 2021 Dec 01; 148(6):. PubMed ID: 34814176
    [Abstract] [Full Text] [Related]

  • 20. Nasal potential difference measurements in patients with atypical cystic fibrosis.
    Wilschanski M, Famini H, Strauss-Liviatan N, Rivlin J, Blau H, Bibi H, Bentur L, Yahav Y, Springer H, Kramer MR, Klar A, Ilani A, Kerem B, Kerem E.
    Eur Respir J; 2001 Jun 01; 17(6):1208-15. PubMed ID: 11491166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.